Haemonetics Corp. (HAE)
118.21
-0.52
(-0.44%)
USD |
NYSE |
Oct 20, 16:00
117.10
-1.11
(-0.94%)
Pre-Market: 07:17
Haemonetics Research and Development Expense (TTM) : 59.43M for June 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 59.43M |
| March 31, 2026 | 58.80M |
| December 31, 2025 | 60.34M |
| September 30, 2025 | 61.89M |
| June 30, 2025 | 63.90M |
| March 31, 2025 | 62.78M |
| December 31, 2024 | 60.82M |
| September 30, 2024 | 57.91M |
| June 30, 2024 | 54.04M |
| March 31, 2024 | 52.23M |
| December 31, 2023 | 52.83M |
| September 30, 2023 | 52.60M |
| June 30, 2023 | 50.83M |
| March 31, 2023 | 49.08M |
| December 31, 2022 | 47.70M |
| September 30, 2022 | 45.04M |
| June 30, 2022 | 45.00M |
| March 31, 2022 | 46.69M |
| December 31, 2021 | 43.27M |
| September 30, 2021 | 40.73M |
| June 30, 2021 | 36.85M |
| March 31, 2021 | 31.69M |
| December 31, 2020 | 30.70M |
| September 30, 2020 | 30.06M |
| June 30, 2020 | 29.96M |
| Date | Value |
|---|---|
| March 31, 2020 | 30.01M |
| December 31, 2019 | 29.96M |
| September 30, 2019 | 32.08M |
| June 30, 2019 | 33.80M |
| March 31, 2019 | 35.71M |
| December 31, 2018 | 38.05M |
| September 30, 2018 | 37.20M |
| June 30, 2018 | 36.14M |
| March 31, 2018 | 34.93M |
| December 31, 2017 | 33.16M |
| September 30, 2017 | 33.50M |
| June 30, 2017 | 34.31M |
| March 31, 2017 | 37.56M |
| December 31, 2016 | 39.98M |
| September 30, 2016 | 42.46M |
| June 30, 2016 | 45.68M |
| March 31, 2016 | 45.56M |
| December 31, 2015 | 51.04M |
| September 30, 2015 | 50.74M |
| June 30, 2015 | 50.13M |
| March 31, 2015 | 54.19M |
| December 31, 2014 | 50.80M |
| September 30, 2014 | 54.36M |
| June 30, 2014 | 54.77M |
| March 31, 2014 | 50.60M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Globus Medical, Inc. | 147.06M |
| Abbott Laboratories | 3.128B |
| ICU Medical, Inc. | 86.32M |
| Merit Medical Systems, Inc. | 98.50M |
| Teleflex, Inc. | 195.47M |